Over 25% of total employer health benefit expenses are now driven by prescription drugs, and within that figure, a small number of specialty drugs account for an outsized share of the cost
Pulses are our e-newsletters that look at recent trends and promising directions across life sciences
A., Tsatalis, J
Asetil l karnitin nedir sorusu, kan-beyin bariyerini aabilen ve sinir sistemi zerinde etkili olan zel bir form olarak yantlanr
Hims & Hers is mass marketing unapproved knock-off versions of Wegovy and Ozempic that evade the FDAs gold standard review processthats dangerous and deceptive to patients and undermines the scientific innovation and regulatory rigor in place to ensure these treatments are safe and effective
173,174 Finally, the absence of well-established regulatory frameworksalongside valid concerns regarding algorithmic bias, data privacy, and accountabilitypresents significant ethical and legal barriers to the broader implementation of AI in clinical settings